Justine Haimi represents clients in connection with the antitrust aspects of litigation, mergers and acquisitions, and advisory matters. She has worked with clients across a diverse range of industries, including health care, medical devices, insurance, technology, telecommunications, energy and pharmaceuticals.

Ms. Haimi has represented clients before the FTC and DOJ in numerous mergers and acquisitions, including ABB Group in its acquisition of GE Industrial Solutions from General Electric Company; Gilead Sciences, Inc. in its acquisition of Kite Pharma, Inc.; Intel Corporation in its spin-out of the Intel Security business; Valeant in its acquisitions of Salix and Synergetics; Leidos Holdings Inc. in its combination with the realigned information systems and global solutions business of Lockheed Martin Corporation; and Nokia in its acquisition of Alcatel-Lucent.

Ms. Haimi’s litigation experience includes defending Allergan in suits brought by private plaintiffs relating to “reverse payment” settlements for Actos and representing Bausch & Lomb in multidistrict litigation challenging its pricing policies relating to disposable contact lenses.

Ms. Haimi also has represented pro bono clients in immigration, veterans affairs and family law matters.



  • J.D., University of Pennsylvania Law School, 2014 (cum laude; Managing Editor, University of Pennsylvania Law Review)
  • M.B.E., University of Pennsylvania, 2014
  • M.H.A., Cornell University, 2011
  • B.S., Cornell University, 2009


  • New York
  • U.S. District Courts for the Southern and Eastern Districts of New York

Justine M. Haimi

Associate, Antitrust/Competition